Jakavi tablet 15 mg 56's
Jakavi tablet contains Ruxolitinib | belongs to Selective inhibitor of Janus-associated tyrosine kinase JAK1 and JAK2
Jakavi tablets are used in the treatment of myelofibrosis, a rare form of blood disorder with a variety of symptoms such as fever, night sweats, bone pain, weight loss. Enlarged spleen is one of the characteristics of myelofibrosis.
Jakavi tablet is sold in Pharmacies at Rs. 175000 in Pakistan. You can buy it on special price from MedicalStore.com.pk
How it works
Jakavi tablet 15 mg 56’s works by blocking your body from producing substances called growth factors.
Frequently asked questions
Onset of action
Duration of Effect
Safe with Alchohol?
Is it habit forming?
Usage in pregnancy?
Usage while breast-feeding?
- webmd.com - Ruxolitinib [Internet]. Available from: https://www.webmd.com/drugs/2/drug-158425/ruxolitinib-oral/details [cited 5/8/2020].
what are the adverse effects of Jakavi tablet 15 mg 56’s?
Urinary tract infection, herpes zoster, anaemia, thrombocytopenia, neutropenia, bleeding, wt gain, hypercholesterolaemia, dizziness, headache, flatulence, raised LFTs.
What happens if I miss a dose of Jakavi tablet 15 mg 56’s?
Adults: Platelets 50000-100000/mm3: 5 mg twice daily; 100000-200000/mm3: 15 mg twice daily; gt;200000/mm3: 20 mg twice daily. Titrate according to response and blood counts; starting dose may be increased after 4 wk by max 5 mg twice daily at gt;2-wk intervals. Max dose 25 mg twice daily. Discontinue if no response after 6 mth, or if 40% increase in baseline spleen length without sustained symptom improvement. Children: Not recommended.
One of the following licensed pharmacy from the nearest location will deliver Jakavi tablet 15 mg 56’s. The details of the licensed pharmacy shall be shared once you request the drugs and the respective pharmacy accepts your request based on valid prescription and availability.